To clarify, they were proposing much more than 30 tests from one drop. They were marketing (to investors, not me but close friends in the industry) the ability to do 100 tests on a drop and then auto-retest from what was left of the same drop for anything that didn't meet some threshold or auto-perform some other indicated test on the basis of a first test result from the original 100-test panel. These numbers are maybe not entirely accurate, but within the ballpark of what was at least implied. All lies/marketing of course, but the dream was real.